| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |